p‐Chlorophenylalanine Changes Serotonin Transporter mRNA Levels and Expression of the Gene Product

Abstract: After a single intraperitoneal injection of the irreversible tryptophan hydroxylase inhibitor p‐chlorophenylalanine (PCPA; 300 mg/kg), there was a rapid down‐regulation of serotonin (5‐HT) transporter mRNA levels in cell bodies. This change was significant at 1 and 2 days after PCPA administration within the ventromedial but not the dorsomedial portion of the dorsal raphe nucleus. Seven days after PCPA treatment, 5‐HT transporter mRNA levels were significantly elevated compared with controls in both regions of the dorsal raphe nucleus. PCPA administration produced no change in the [3H]‐citalopram binding and synaptosomal [3H]5‐HT uptake in terminal regions at 2 and 7 days after treatment but significantly reduced both these parameters by ∼20% in the hippocampus and in cerebral cortex 14 days after PCPA administration. The striatum showed a lower sensitivity to this effect. No significant changes were observed in the levels of [3H]citalopram binding to 5‐HT cell bodies in the dorsal raphe nucleus. In the same animals used for 5‐HT transporter mRNA level measurements, levels of tryptophan hydroxylase mRNA in neurons of the ventromedial and dorsomedial portions of the dorsal raphe nucleus were increased 2 days after PCPA administration and fell to control levels 7 days after injection in the ventromedial region but not in the dorsomedial portion of the dorsal raphe nucleus, where they remained significantly higher than controls. Altogether, these results show that changes in 5‐HT transporter mRNA are not temporally related to changes in 5‐HT transporter protein levels. In addition, our results suggest that the 5‐HT transporter and tryptophan hydroxylase genes are regulated by different mechanisms. We also provide further evidence that dorsal raphe 5‐HT neurons are differentially regulated by drugs, depending on their location.

[1]  V. P. Whittaker,et al.  The isolation of nerve endings from brain: an electron-microscopic study of cell fragments derived by homogenization and centrifugation. , 1962, Journal of anatomy.

[2]  W. Lovenberg,et al.  Tryptophan hydroxylase inhibition: the mechanism by which p-chlorophenylalanine depletes rat brain serotonin. , 1967, Molecular pharmacology.

[3]  A. Weissman,et al.  The pharmacology of para-chlorophenylalanine, a selective depletor of serotonin stores. , 1968, Advances in pharmacology.

[4]  R. P. Maickel,et al.  Comparative effects of p-chlorophenylalanine, p-chloroamphetamine and p-chloro-N-methylamphetamine on rat brain norepinephrine, serotonin and 5-hydroxyindole-3-acetic acid☆ , 1970 .

[5]  L. Swanson.  The Rat Brain in Stereotaxic Coordinates, George Paxinos, Charles Watson (Eds.). Academic Press, San Diego, CA (1982), vii + 153, $35.00, ISBN: 0 125 47620 5 , 1984 .

[6]  S. Garattini,et al.  Neurochemical mechanism of action of drugs which modify feeding via the serotoninergic system , 1986, Appetite.

[7]  H. Kimura,et al.  Quantitative morphometric analysis of two types of serotonin-immunoreactive nerve fibres differentially responding to p-chlorophenylalanine treatment in the rat brain , 1988, Neuroscience.

[8]  J. Mallet,et al.  Sequence of Two mRNAs Encoding Active Rat Tryptophan Hydroxylase , 1988, Journal of neurochemistry.

[9]  M. Darmon,et al.  Differential control of tryptophan hydroxylase expression in raphe and in pineal gland: Evidence for a role of translation efficiency , 1989, Journal of neuroscience research.

[10]  S. Garattini,et al.  Effect of L-cysteine on the long-term depletion of brain indoles caused by p-chloroamphetamine and d-fenfluramine in rats. Relation to brain drug concentrations. , 1989, European journal of pharmacology.

[11]  J. Contrera,et al.  Effects of repeated fenfluramine administration on indices of monoamine function in rat brain: pharmacokinetic, dose response, regional specificity and time course data. , 1990, The Journal of pharmacology and experimental therapeutics.

[12]  J. Pujol,et al.  Variation of tryptophan-5-hydroxylase concentration in the rat raphe dorsalis nucleus afterp-chlorophenylalanine administration. II. Anatomical distribution of the tryptophan-5-hydroxylase protein and regional variation of its turnover rate , 1990, Brain Research.

[13]  G. Forloni,et al.  Increased tryptophan hydroxylase mRNA in raphe serotonergic neurons spared by 5,7-dihydroxytryptamine. , 1990, Brain research. Molecular brain research.

[14]  J. Pujol,et al.  Variation of tryptophan-5-hydroxylase concentration in the rat raphe dorsalis nucleus afterp-chlorophenylalanine administration. I. A model to study the turnover of the enzymatic protein , 1990, Brain Research.

[15]  J. Contrera,et al.  Effects of high‐dose fenfluramine treatment on monoamine uptake sites in rat brain: Assessment using quantitative autoradiography , 1990, Synapse.

[16]  R. Blakely,et al.  Cloning and expression of a functional serotonin transporter from rat brain , 1991, Nature.

[17]  M. Brownstein,et al.  Cloning of a serotonin transporter affected by antidepressants. , 1991, Science.

[18]  D. Brunswick,et al.  Effect of repeated administration of antidepressants on serotonin uptake sites in limbic and neocortical structures of rat brain determined by quantitative autoradiography. , 1992, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology.

[19]  M. Gobbi,et al.  Releasing activities of d-fenfluramine and fluoxetine on rat hippocampal synaptosomes preloaded with [3H]serotonin. , 1992, Naunyn-Schmiedeberg's archives of pharmacology.

[20]  D. Brunswick,et al.  Effects of high‐dose methamphetamine on monoamine uptake sites in rat brain measured by quantitative autoradiography , 1992, Synapse.

[21]  G. Rudnick,et al.  The molecular mechanism of "ecstasy" [3,4-methylenedioxy-methamphetamine (MDMA)]: serotonin transporters are targets for MDMA-induced serotonin release. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[22]  D. Murphy,et al.  Regional brain expression of serotonin transporter mRNA and its regulation by reuptake inhibiting antidepressants. , 1993, Brain research. Molecular brain research.

[23]  P. Hrdina,et al.  Chronic fluoxetine treatment upregulates 5‐HT uptake sites and 5‐HT2 receptors in rat brain: An autoradiographic study , 1993, Synapse.

[24]  P. Celada,et al.  p‐Chlorophenylalanine Increases Tryptophan‐5‐Hydroxylase mRNA Levels in the Rat Dorsal Raphe: A Time Course Study Using In Situ Hybridization , 1993, Journal of neurochemistry.

[25]  Mark A. Smith,et al.  The effect of chronic imipramine administration on the densities of 5-HT1A and 5-HT2 receptors and the abundancies of 5-HT receptor and transporter mRNA in the cortex, hippocampus and dorsal raphe of three strains of rat , 1994, Brain Research.

[26]  M. Gobbi,et al.  Differential effects of 5,7-dihydroxytryptamine-induced serotoninergic degeneration on 5-HT1A receptors and 5-HT uptake sites in the rat brain , 1994, Journal of Chemical Neuroanatomy.

[27]  D. H. Park,et al.  Early induction of rat brain tryptophan hydroxylase (TPH) mRNA following parachlorophenylalanine (PCPA) treatment. , 1994, Brain research. Molecular brain research.

[28]  S. Hamada,et al.  PCPA reduces both monoaminergic afferents and nonmonoaminergic synapses in the cerebral cortex , 1994, Neuroscience Research.

[29]  H. Akil,et al.  Serotonin transporter mRNA in rat brain is regulated by classical antidepressants , 1994, Biological Psychiatry.

[30]  P. McGuffin,et al.  Lack of effect of antidepressant drugs on the levels of mRNAs encoding serotonergic receptors, synthetic enzymes and 5HT transporter , 1994, Neuropharmacology.

[31]  Ove Wiborg,et al.  Serotonin depletion decreases serotonin transporter mRNA levels in rat brain , 1995, Brain Research.